The Patent Finder

Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Friedreich Ataxia

Université Paris-Sud

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,337,027Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Friedreich Ataxia
In force
 · Low confidence
UsedRemaining
Institut National de la Santé et de la Recherche Médicale (Inserm), Université Paris-Sud XI and Assistance Publique - Hôpitaux de Paris (Aphp)In forceLow confidence
Application 16/411,997Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure
Abandoned
Abandoned Apr 7, 2021
Institut National de la Santé et de la Recherche Médicale (Inserm), Université Paris-Sud XI and Assistance Publique - Hôpitaux de Paris (Aphp)AbandonedAbandoned Apr 7, 2021
Application 14/764,065Methods and Pharmaceutical Composition for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure
Abandoned
Abandoned Apr 1, 2018
Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris-Sud XI and Assistance Publique-Hopitaux de ParisAbandonedAbandoned Apr 1, 2018
Application 15/916,907Methods and Pharmaceutical Composition for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure
Abandoned
Abandoned Dec 4, 2020
Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris-Sud XI and Assistance Publique-Hopitaux de ParisAbandonedAbandoned Dec 4, 2020
Application 17/103,783Methods and Pharmaceutical Composition for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure
Abandoned
Abandoned Jun 24, 2024
Université Paris-SaclayAbandonedAbandoned Jun 24, 2024
Application 17/222,500Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure
Abandoned
Abandoned May 25, 2024
Université Paris-SaclayAbandonedAbandoned May 25, 2024
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Université Paris-Sud.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited